Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 70 publications
Presenting and residual movement disorders in all-cause autoimmune encephalitis.
Journal: Journal of neuroimmunology
Published: May 10, 2026
Comparative Effectiveness of Disease-Modifying Treatments in Double Seronegative Neuromyelitis Optica Spectrum Disorder.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: April 16, 2026
Ocular-motor conduction dynamics and variability in multiple sclerosis-related internuclear ophthalmoparesis: A randomized dalfampridine trial.
Journal: Multiple sclerosis journal - experimental, translational and clinical
Published: April 10, 2026
Real world predictors of hypogammaglobulinemia and serious infections in patients receiving ocrelizumab or ofatumumab for the treatment of multiple sclerosis: The REPLACE-MS study.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: February 10, 2026
Comparative Effectiveness of Disease-Modifying Treatments in Double Seronegative Neuromyelitis Optica Spectrum Disorder.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: February 04, 2026
Alternative diagnoses in patients referred to neuroimmunology for autoimmune encephalitis evaluation.
Journal: Journal of neurology
Published: September 23, 2025
Immune checkpoint inhibitor-associated encephalitis and inflammation: Emerging signals, evolving challenges.
Journal: Clinical neurology and neurosurgery
Published: September 21, 2025
Factors influencing timeliness of reporting results from multiple sclerosis related clinical trials to ClinicalTrials.gov.
Journal: Journal of the neurological sciences
Published: August 05, 2025
Satralizumab treatment in adults with aquaporin-4 immunoglobulin G-seropositive neuromyelitis optica spectrum disorder in clinical practice.
Journal: Multiple sclerosis journal - experimental, translational and clinical
Published: May 29, 2025
The Clinical Trial Landscape in Autoimmune Encephalitis: Challenges and Opportunities.
Journal: Neurology
Published: March 27, 2025
Movement disorders in relapsing and progressive MS: A comprehensive prospective evaluation of a large real-life cohort.
Journal: Journal of the neurological sciences
Published: January 10, 2025
Switch from eculizumab to satralizumab in aquaporin 4 immunoglobulin G-seropositive neuromyelitis optica spectrum disorder: a case series report.
Journal: Frontiers in immunology
Published: November 12, 2024
Last Updated: 09/26/2026